Betaloan Suik Injection, Suspension
Product Images NDC 76420-240

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Betaloan Suik (NDC 76420-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Betamethasone Sodium Phosphate (Bet0b 0002 01)

Chemical structure of Betamethasone Sodium Phosphate, the active ingredient in Betaloan SUIK injection suspension by Asclemed USA, Inc.*

FDA Label Image

Betamethasone Acetate (Bet0b 0002 02)

Chemical structure of Betamethasone Acetate, an active ingredient in Betaloan SUIK injection suspension.*

FDA Label Image

Principal Display Panel – Carton Label (Bet0b 0002 03)

The packaging label for Betaloan SUIK injection suspension by Asclemed USA, Inc. It contains Betamethasone Sodium Phosphate and Betamethasone Acetate 6 mg/mL in a 5 mL vial. The kit includes syringes with BD PrecisionGlide needles, Gebauer's Pain Ease 30 mL, sterile gloves, adhesive bandage, isopropyl alcohol prep pad, gauze, and a face mask. Distributed by Enovachem Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.